Skip to content

A study to assess the safety and effectiveness of a skincare product

To evaluate the in vivo efficacy and safety of a skin care formulation in terms of reduction in appearance of stretch marks (For Female on Lower Abdomen and Thighs and For Male on Thighs and Arms) and skin hydration on healthy male and female subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110822
Enrollment
30
Registered
2026-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Skinvest Bomb Bum Cream: The product is applied twice daily for a period of 56 days: by female subjects on the lower abdomen and thighs, and by male subjects on the thighs and arms Cont

Sponsors

Skinvest
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian male & female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Having visible stretch marks in the arms & thigh area for male and abdomen & thighs area for female

Exclusion criteria

Exclusion criteria: 1 Presence of keloids or hypertrophic scars in the study area. 2. Severe or inflamed stretch marks (study is focused on mild moderate cases). 3.Subjects with high risk of post-inflammatory hyperpigmentation (PIH). 4. Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 5. Having refused to give her/his assent by signing the consent form. 6.Taking part in another study liable to interfere with this study. 7. Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 8. Being asthmatic. 9. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex 10. following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 11. Having cutaneous hypersensitivity. 12.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 13. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 14. having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit. 15. Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only test site cleaned with water is accepted)

Design outcomes

Primary

MeasureTime frame
Product safety, reduction in appearance of stretch marks (For Female on Lower Abdomen & Thighs and For Male on Thighs & Arms) and skin hydrationTimepoint: Baseline, day 28 and day 56

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in8657063276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026